Literature DB >> 33505778

miR-875-5p exerts tumor-promoting function via down-regulation of CAPZA1 in esophageal squamous cell carcinoma.

Nan Kang1,2, Yunwei Ou1, Guangchao Wang1, Jie Chen3, Dan Li1, Qimin Zhan1,3.   

Abstract

Esophageal squamous cell carcinoma (ESCC) is one of the leading causes of cancer deaths worldwide. Currently, efficient genetic markers for diagnosis and treatment of ESCC are lacking. MicroRNAs (miRNAs) are global genetic regulators that control cancer gene expression by binding to the 3'untranslated regions (3'UTRs) of targeting mRNAs. In addition, miRNAs function as oncogenes or tumor suppressors in the progression of tumors. In the current study, we found that hsa-miR-875-5p (miR-875-5p) exhibited amplification in ESCC according to the TCGA database. Then, xCELLigence Real-Time Cell Analyzer (RTCA)-MP system and colony formation assays were employed to detect cell proliferationand colony formationability. The results showed that miR-875-5p promoted the proliferation ESCC cells. Subsequently, transwell results indicated that miR-875-5p promoted the invasion and migration of ESCC cells. Furthermore, we showed that miR-875-5p was able to bind to CAPZA13'UTR, which contains the single nucleotide polymorphism (SNP), rs373245753, as reported in our previous study involving WGS and WES on ESCC. Subsequently, mRNA affinity pull-down assays verifiedthat the SNP disrupts miR-875-5p binding to CAPZA1. The current study is the first demonstration that miR-875-5p may function as an oncogene via down-regulation of CAPZA1 expression in ESCC. ©2021 Kang et al.

Entities:  

Keywords:  Down-regulate; SNP; miR-875-5p; CAPZA1; ESCC

Year:  2021        PMID: 33505778      PMCID: PMC7792515          DOI: 10.7717/peerj.10020

Source DB:  PubMed          Journal:  PeerJ        ISSN: 2167-8359            Impact factor:   2.984


  36 in total

1.  Proteomics-based identification of spontaneous regression-associated proteins in neuroblastoma.

Authors:  Fang Yu; Xiudan Zhu; Chen Feng; Tianyou Wang; Qin Hong; Zhoulu Liu; Suoqin Tang
Journal:  J Pediatr Surg       Date:  2011-10       Impact factor: 2.545

2.  Functional SNP in the microRNA-367 binding site in the 3'UTR of the calcium channel ryanodine receptor gene 3 (RYR3) affects breast cancer risk and calcification.

Authors:  Lina Zhang; Yuexin Liu; Fengju Song; Hong Zheng; Limei Hu; Hong Lu; Peifang Liu; Xishan Hao; Wei Zhang; Kexin Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-02       Impact factor: 11.205

Review 3.  MicroRNAs function as tumor suppressors or oncogenes: aberrant expression of microRNAs in head and neck squamous cell carcinoma.

Authors:  Nijiro Nohata; Toyoyuki Hanazawa; Takashi Kinoshita; Yoshitaka Okamoto; Naohiko Seki
Journal:  Auris Nasus Larynx       Date:  2012-07-24       Impact factor: 1.863

4.  Identification of genomic alterations in oesophageal squamous cell cancer.

Authors:  Yongmei Song; Lin Li; Yunwei Ou; Zhibo Gao; Enmin Li; Xiangchun Li; Weimin Zhang; Jiaqian Wang; Liyan Xu; Yong Zhou; Xiaojuan Ma; Lingyan Liu; Zitong Zhao; Xuanlin Huang; Jing Fan; Lijia Dong; Gang Chen; Liying Ma; Jie Yang; Longyun Chen; Minghui He; Miao Li; Xuehan Zhuang; Kai Huang; Kunlong Qiu; Guangliang Yin; Guangwu Guo; Qiang Feng; Peishan Chen; Zhiyong Wu; Jianyi Wu; Ling Ma; Jinyang Zhao; Longhai Luo; Ming Fu; Bainan Xu; Bo Chen; Yingrui Li; Tong Tong; Mingrong Wang; Zhihua Liu; Dongxin Lin; Xiuqing Zhang; Huanming Yang; Jun Wang; Qimin Zhan
Journal:  Nature       Date:  2014-03-16       Impact factor: 49.962

5.  An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity.

Authors:  Jessika Wynendaele; Anja Böhnke; Eleonora Leucci; Søren Jensby Nielsen; Irina Lambertz; Stefanie Hammer; Nadja Sbrzesny; Dana Kubitza; Anja Wolf; Elise Gradhand; Katharina Balschun; Ioana Braicu; Jalid Sehouli; Silvia Darb-Esfahani; Carsten Denkert; Christoph Thomssen; Steffen Hauptmann; Anders Lund; Jean-Christophe Marine; Frank Bartel
Journal:  Cancer Res       Date:  2010-11-16       Impact factor: 12.701

6.  Natural selection on human microRNA binding sites inferred from SNP data.

Authors:  Kevin Chen; Nikolaus Rajewsky
Journal:  Nat Genet       Date:  2006-10-29       Impact factor: 38.330

7.  p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC.

Authors:  N R Christoffersen; R Shalgi; L B Frankel; E Leucci; M Lees; M Klausen; Y Pilpel; F C Nielsen; M Oren; A H Lund
Journal:  Cell Death Differ       Date:  2009-08-21       Impact factor: 15.828

8.  S100A8 is identified as a biomarker of HPV18-infected oral squamous cell carcinomas by suppression subtraction hybridization, clinical proteomics analysis, and immunohistochemistry staining.

Authors:  Wan-Yu Lo; Chien-Chen Lai; Chun-Hung Hua; Ming-Hsui Tsai; Shiuan-Yi Huang; Chang-Hai Tsai; Fuu-Jen Tsai
Journal:  J Proteome Res       Date:  2007-04-24       Impact factor: 4.466

Review 9.  Oncomirs - microRNAs with a role in cancer.

Authors:  Aurora Esquela-Kerscher; Frank J Slack
Journal:  Nat Rev Cancer       Date:  2006-04       Impact factor: 60.716

10.  Hsa-miR-875-5p exerts tumor suppressor function through down-regulation of EGFR in colorectal carcinoma (CRC).

Authors:  Tiening Zhang; Xun Cai; Qi Li; Peng Xue; Zhixiao Chen; Xiao Dong; Ying Xue
Journal:  Oncotarget       Date:  2016-07-05
View more
  3 in total

1.  Hsa_circ_NOTCH3 regulates ZNF146 through sponge adsorption of miR-875-5p to promote tumorigenesis of hepatocellular carcinoma.

Authors:  Lei Bao; Min Wang; Qiqi Fan
Journal:  J Gastrointest Oncol       Date:  2021-10

2.  MicroRNA Alterations Induced in Human Skin by Diesel Fumes, Ozone, and UV Radiation.

Authors:  Giuseppe Valacchi; Erika Pambianchi; Simona Coco; Alessandra Pulliero; Alberto Izzotti
Journal:  J Pers Med       Date:  2022-01-28

3.  hsa-miR-875-5p inhibits tumorigenesis and suppresses TGF-β signalling by targeting USF2 in gastric cancer.

Authors:  Shenshuo Gao; Zhikai Zhang; Xubin Wang; Yan Ma; Chensheng Li; Hongjun Liu; Changqing Jing; Leping Li; Xiaobo Guo
Journal:  J Transl Med       Date:  2022-03-07       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.